Thrombotic diseases, in particular cardiovascular and cerebrovascular thrombotic diseases, have become the top cause of death in the population of China, and their incidence has increased, seriously endangering human health.

China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

C2i Genomics launches minimal residual disease test across Europe after clearing regulatory hurdles in the EU, UK, and Switzerland.

BioMérieux on Tuesday announced it has entered into an agreement to acquire Specific Diagnostics for an acquisition price equivalent to 3.3 percent of BioMérieux's market capitalization as of April 11, paid with a combination of cash and shares issued to Specific Diagnostics shareholders.

On April 13, National Medical Products Administrations (NMPA) reviewed and approved Zhuhai Livzon Diagnostics Inc. and Shanghai BioGerm Medical Technology Co., Ltd's COVID-19 Antigen Test.

The US Food and Drug Administration last week granted separate Emergency Use Authorizations for a PCR-based SARS-CoV-2 test developed by the University of California, San Diego and an at-home nasal specimen collection kit from the Washington D.C. Department of Health.

Medical advances are causing a gradual increase in average life expectancy. However, this comes at a price, as the number of cases of dementia and other neurodegenerative diseases grows with age.

CLS.CN reported on April 12 that Andon Health announced that the net profit in the first quarter is expected to be CNY 14 billion to CNY 16 billion, a year-on-year increase of 36707.43% to 41965.63%.

ECDC and EMA have concluded that it is too early to consider using a fourth dose of mRNA COVID-19 vaccines in the general population.

The US Food and Drug Administration this week granted separate Emergency Use Authorizations for over-the-counter SARS-CoV-2 antigen self-tests developed by Osang Healthcare.

A few days ago, the Department of Planning, Development and Information Technology of the China National Health and Medical Commission issued the "Notice of the Office of the Healthy China Action Promotion Committee on Printing and Distributing the Work Points of the Healthy China Action in 2022".

Quidel on Thursday said that it expects its first quarter revenues to nearly triple year over year, primarily on sales of COVID-19 testing products.